Page last updated: 2024-10-29

ifosfamide and Experimental Mammary Neoplasms

ifosfamide has been researched along with Experimental Mammary Neoplasms in 8 studies

Research Excerpts

ExcerptRelevanceReference
" An extension of the comparative study to the in vivo model of murine C3H mammary adenocarcinoma yielded synergistic effects, if the animals were treated with 10 MeV electrons and one of the drugs: cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosphamide."7.68Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosph ( Ulmer, W, 1991)
" An extension of the comparative study to the in vivo model of murine C3H mammary adenocarcinoma yielded synergistic effects, if the animals were treated with 10 MeV electrons and one of the drugs: cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosphamide."3.68Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosph ( Ulmer, W, 1991)
"Three murine tumor lines, B16 melanoma, C38 colon cancer and M2661 breast cancer, were used to evaluate the therapeutic efficacy of the drug combination ACNU and ifosfamide."3.68Combination therapy of ACNU and ifosfamide in tumor bearing mice with M2661 breast cancer, B16 malignant melanoma or C38 colon cancer. ( Nooter, K; Silbermann, MH; Stoter, G; vd Vecht, B; Verweij, J, 1990)
" Oral bioavailability in rats was 48-73% of parenteral administration, and antitumor activity in mice was equivalent by both routes."1.38Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin. ( Amedio, J; Jones, B; Komarnitsky, P; Miller, GT; Wallner, BP, 2012)
"Ifosfamide (IFF) is a nitrogen mustard with significant activity against a number of tumors."1.29Efficacy and toxicity of ifosfamide stereoisomers in an in vivo rat mammary carcinoma model. ( Batist, G; Granvil, CP; Wainer, IW; Wang, T, 1994)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's3 (37.50)18.2507
2000's1 (12.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jones, B1
Komarnitsky, P1
Miller, GT1
Amedio, J1
Wallner, BP1
Struck, RF1
Dykes, DJ1
Corbett, TH1
Suling, WJ1
Trader, MW1
Wainer, IW1
Granvil, CP1
Wang, T1
Batist, G1
Kammertoens, T1
Gelbmann, W1
Karle, P1
Alton, K1
Saller, R1
Salmons, B1
Günzburg, WH1
Uckert, W1
Ulmer, W1
Silbermann, MH1
vd Vecht, B1
Stoter, G1
Nooter, K1
Verweij, J1
Kuśnierczyk, H1
Radzikowski, C1
Paprocka, M1
Budzyński, W1
Rak, J1
Kinas, R1
Misiura, K1
Stec, W1

Other Studies

8 other studies available for ifosfamide and Experimental Mammary Neoplasms

ArticleYear
Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin.
    Anti-cancer drugs, 2012, Volume: 23, Issue:2

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols

2012
Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
    British journal of cancer, 1983, Volume: 47, Issue:1

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Cyclophosphamide;

1983
Efficacy and toxicity of ifosfamide stereoisomers in an in vivo rat mammary carcinoma model.
    Cancer research, 1994, Aug-15, Volume: 54, Issue:16

    Topics: Animals; Body Weight; Bone Marrow; Drug Screening Assays, Antitumor; Female; Ifosfamide; Lethal Dose

1994
Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine.
    Cancer gene therapy, 2000, Volume: 7, Issue:4

    Topics: Animals; Cats; Cell Line; Cell Transplantation; Cytochrome P-450 CYP2B1; Cytosine Deaminase; Female;

2000
Report on carcinogenesis bioassay of isophosphamide.
    American Industrial Hygiene Association journal, 1978, Volume: 39, Issue:6

    Topics: Animals; Carcinogens; Cyclophosphamide; Cystitis; Dogs; Female; Hair; Ifosfamide; Lymphoma; Male; Ma

1978
Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosph
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1991, Volume: 167, Issue:9

    Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Biophysical Phenomena; Biop

1991
Combination therapy of ACNU and ifosfamide in tumor bearing mice with M2661 breast cancer, B16 malignant melanoma or C38 colon cancer.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Synergism; Ifosfami

1990
Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
    Journal of immunopharmacology, 1986, Volume: 8, Issue:4

    Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation, Preclinical; Female; Ifosfamide;

1986